Herbert Y. Meltzer, M.D.

Original Research

Cariprazine in Acute Exacerbation of Schizophrenia: A Fixed-Dose, Phase 3, Randomized, Double-Blind, Placebo- and Active-Controlled Trial

December 23, 2015

Suresh Durgam, Andrew J. Cutler, Kaifeng Lu, et al

Original Research

A Randomized, Double-Blind, Placebo-Controlled Trial of Aripiprazole Lauroxil in Acute Exacerbation of Schizophrenia

August 26, 2015

Herbert Y. Meltzer, Robert Risinger, Henry A. Nasrallah, et al

Article

Sulfotransferase 4A1 Haplotype 1 (SULT4A1-1) Is Associated With Decreased Hospitalization Events in Antipsychotic-Treated Patients With Schizophrenia

May 24, 2012

The objective of this study was to evaluate a common genetic variant, sulfotransferase 4A1 haplotype 1 (SULT4A1-1), as a predictor of hospitalization events due to the exacerbation of schizophrenia...

Qian Liu, Timothy L. Ramsey, Herbert Y. Meltzer, et al

Original Research

A 12-Month Randomized, Open-Label Study of the Metabolic Effects of Olanzapine and Risperidone in Psychotic Patients: Influence of Valproic Acid Augmentation

July 12, 2011

Herbert Y. Meltzer, Stefania Bonaccorso, William V. Bobo, et al

Consensus Statement

Suicidality and Risk of Suicide—Definition, Drug Safety Concerns, and a Necessary Target for Drug Development: A Consensus Statement

August 16, 2010

Roger E. Meyer, Carl Salzman, Eric A. Youngstrom, et al

Consensus Statement

Suicidality and Risk of Suicide—Definition, Drug Safety Concerns, and a Necessary Target for Drug Development: A Brief Report

July 13, 2010

Roger E. Meyer, Carl Salzman, Eric A. Youngstrom, et al

Letter to the Editor

Drs. Meltzer and Jayathilake Reply

October 31, 2008

Herbert Y. Meltzer, Karu Jayathilake

Original Research

Efficacy and Tolerability of Oral Paliperidone Extended-Release Tablets in the Treatment of Acute Schizophrenia: Pooled Data From Three 6-Week, Placebo-Controlled Studies

May 11, 2008

Herbert Y. Meltzer, William V. Bobo, Isaac F. Nuamah, et al

Original Research

A Randomized, Double-Blind Comparison of Clozapine and High-Dose Olanzapine in Treatment-Resistant Patients With Schizophrenia

February 14, 2008

Herbert Y. Meltzer, William V. Bobo, Ajanta Roy, et al

Letter to the Editor

Reply to Aripiprazole and Perphenazine: No Difference

November 15, 2007

John M. Kane, Herbert Y. Meltzer, William H. Carson, Jr., et al

Original Research

Aripiprazole for Treatment-Resistant Schizophrenia: Results of a Multicenter, Randomized, Double-Blind, Comparison Study Versus Perphenazine

February 15, 2007

John M. Kane, Herbert Y. Meltzer, William H. Carson, Jr., et al

Original Research

A Double-Blind Study of Combination of Clozapine With Risperidone in Patients With Schizophrenia: Effects on Cognition

December 15, 2006

Berna Binnur Kıvırcık Akdede, Köksal Alptekin, Tolga İ. Turgut, et al

Cariprazine in Acute Exacerbation of Schizophrenia: A Fixed-Dose, Phase 3, Randomized, Double-Blind, Placebo- and Active-Controlled Trial

A Randomized, Double-Blind, Placebo-Controlled Trial of Aripiprazole Lauroxil in Acute Exacerbation of Schizophrenia

Sulfotransferase 4A1 Haplotype 1 (SULT4A1-1) Is Associated With Decreased Hospitalization Events in Antipsychotic-Treated Patients With Schizophrenia

A 12-Month Randomized, Open-Label Study of the Metabolic Effects of Olanzapine and Risperidone in Psychotic Patients: Influence of Valproic Acid Augmentation

Suicidality and Risk of Suicide—Definition, Drug Safety Concerns, and a Necessary Target for Drug Development: A Consensus Statement

Suicidality and Risk of Suicide—Definition, Drug Safety Concerns, and a Necessary Target for Drug Development: A Brief Report

Drs. Meltzer and Jayathilake Reply

Efficacy and Tolerability of Oral Paliperidone Extended-Release Tablets in the Treatment of Acute Schizophrenia: Pooled Data From Three 6-Week, Placebo-Controlled Studies

A Randomized, Double-Blind Comparison of Clozapine and High-Dose Olanzapine in Treatment-Resistant Patients With Schizophrenia

Reply to Aripiprazole and Perphenazine: No Difference

Aripiprazole for Treatment-Resistant Schizophrenia: Results of a Multicenter, Randomized, Double-Blind, Comparison Study Versus Perphenazine

A Double-Blind Study of Combination of Clozapine With Risperidone in Patients With Schizophrenia: Effects on Cognition

ELSEWHERE:

FOLLOW US:

Herbert Y. Meltzer, M.D.

Cariprazine in Acute Exacerbation of Schizophrenia: A Fixed-Dose, Phase 3, Randomized, Double-Blind, Placebo- and Active-Controlled Trial

A Randomized, Double-Blind, Placebo-Controlled Trial of Aripiprazole Lauroxil in Acute Exacerbation of Schizophrenia

Sulfotransferase 4A1 Haplotype 1 (SULT4A1-1) Is Associated With Decreased Hospitalization Events in Antipsychotic-Treated Patients With Schizophrenia

A 12-Month Randomized, Open-Label Study of the Metabolic Effects of Olanzapine and Risperidone in Psychotic Patients: Influence of Valproic Acid Augmentation

Suicidality and Risk of Suicide—Definition, Drug Safety Concerns, and a Necessary Target for Drug Development: A Consensus Statement

Suicidality and Risk of Suicide—Definition, Drug Safety Concerns, and a Necessary Target for Drug Development: A Brief Report

Drs. Meltzer and Jayathilake Reply

Efficacy and Tolerability of Oral Paliperidone Extended-Release Tablets in the Treatment of Acute Schizophrenia: Pooled Data From Three 6-Week, Placebo-Controlled Studies

A Randomized, Double-Blind Comparison of Clozapine and High-Dose Olanzapine in Treatment-Resistant Patients With Schizophrenia

Reply to Aripiprazole and Perphenazine: No Difference

Aripiprazole for Treatment-Resistant Schizophrenia: Results of a Multicenter, Randomized, Double-Blind, Comparison Study Versus Perphenazine

A Double-Blind Study of Combination of Clozapine With Risperidone in Patients With Schizophrenia: Effects on Cognition

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles